Puma Biotechnology Inc (PBYI)
4.26
-0.15
(-3.40%)
USD |
NASDAQ |
May 17, 12:12
Puma Biotechnology Cash and Short Term Investments (Quarterly): 107.16M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 107.16M |
December 31, 2023 | 95.94M |
September 30, 2023 | 85.03M |
June 30, 2023 | 74.44M |
March 31, 2023 | 71.22M |
December 31, 2022 | 81.07M |
September 30, 2022 | 77.96M |
June 30, 2022 | 60.75M |
March 31, 2022 | 73.91M |
December 31, 2021 | 82.11M |
September 30, 2021 | 87.54M |
June 30, 2021 | 108.98M |
March 31, 2021 | 109.05M |
December 31, 2020 | 93.39M |
September 30, 2020 | 109.02M |
June 30, 2020 | 107.27M |
March 31, 2020 | 100.56M |
December 31, 2019 | 111.64M |
September 30, 2019 | 110.44M |
June 30, 2019 | 117.66M |
March 31, 2019 | 150.40M |
December 31, 2018 | 165.42M |
September 30, 2018 | 127.95M |
June 30, 2018 | 134.51M |
March 31, 2018 | 78.55M |
Date | Value |
---|---|
December 31, 2017 | 81.70M |
September 30, 2017 | 106.34M |
June 30, 2017 | 151.65M |
March 31, 2017 | 193.98M |
December 31, 2016 | 229.48M |
September 30, 2016 | 108.93M |
June 30, 2016 | 143.79M |
March 31, 2016 | 181.21M |
December 31, 2015 | 215.89M |
September 30, 2015 | 247.78M |
June 30, 2015 | 282.37M |
March 31, 2015 | 310.33M |
December 31, 2014 | 141.33M |
September 30, 2014 | 153.86M |
June 30, 2014 | 178.35M |
March 31, 2014 | 196.11M |
December 31, 2013 | 83.95M |
September 30, 2013 | 95.64M |
June 30, 2013 | 107.52M |
March 31, 2013 | 118.72M |
December 31, 2012 | 137.41M |
September 30, 2012 | 33.35M |
June 30, 2012 | 41.00M |
March 31, 2012 | 50.17M |
December 31, 2011 | 53.38M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
60.75M
Minimum
Jun 2022
117.66M
Maximum
Jun 2019
93.26M
Average
94.66M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
ADMA Biologics Inc | 45.32M |
Pfizer Inc | 11.93B |
Sarepta Therapeutics Inc | 1.391B |
Immunogen Inc (DELISTED) | 605.54M |
United Therapeutics Corp | 2.708B |